CD137/NF-κB Reporter - HEK293 Recombinant Cell Line

Catalog #: 79289
Size: 2 vials
$7,500
Background:
Human CD137 (4-1BB; TNFRS9) is an inducible co-stimulatory molecule that activates T cells. CD137:CD137L-mediated signaling has been shown to be important for proliferation, effector functions and survivals of T cells. CD137 is also expressed in NK and NKT cells. Accumulating evidence shows a role for CD137:CD137L signaling in inflammation, suggesting that inhibition of this pathway may provide a therapeutic avenue to treat autoimmune and inflammatory diseases. Similarly, antibodies targeting CD137 activation in immune cells have demonstrated potent anti-tumor properties in cancer patients.
Description:
Recombinant HEK293 cell line expressing a full length human CD137 (NM_003811). The NF-ĸB luciferase reporter construct is stably integrated into the genome. The firefly luciferase gene is controlled by 4 copies of NF-κB response element located upstream of the TATA promoter. Following activation by human CD137 ligand, NF-ĸB transcription factors bind to the DNA response elements to induce transcription of the luciferase gene.
Synonym(s):
CD137, 4-1BB
Host Cell line:
HEK293
Growth Media:

Thaw Medium 1 (BPS Bioscience, #60187): This medium, optimized for plating and thawing HEK293 cells, includes includes 10% FBS, non-essential amino acids, sodium pyruvate, and 1% Penicillin/Streptomycin.

Complete Growth Medium: Thaw Medium 1 (BPS Bioscience, #60187) plus 400 µg/ml G418 (Geneticin) and 50 µg/ml Hygromycin B (Thermo Fisher, #10687010).

Format:
Each vial contains 2 x 10^6 cells in 1 ml of 10% DMSO in FBS.
Storage / Stability:
Store in liquid nitrogen immediately upon receipt.
Application(s):
• Screen for activators or inhibitors of CD137 signaling in a cellular context

• Characterize the biological activity of CD137 and its interactions with ligands

Notes:
Purchase of this cell line grants you with a 10-year license to use this cell line in your immediate laboratory, for research use only. This license does not permit you to share, distribute, sell, sublicense, or otherwise make the cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. The license does not permit use of this cell line in humans or for therapeutic or drug use. The license does not permit modification of the cell line in any way. Inappropriate use or distribution of this cell line will result in revocation of the license and result in an immediate cease of sales and distribution of BPS products to your laboratory. BPS does not warrant the suitability of the cell line for any particular use, and does not accept any liability in connection with the handling or use of the cell line. Modifications of this cell line, transfer to another facility, or commercial use of the cells may require a separate license and additional fees; contact sales@bpsbioscience.com for details. Publications using this cell line should reference BPS Bioscience, Inc., San Diego.
Scientific Category:
Immunotherapy
Product Type:
Cell Line
Data shown is lot-specific. Contact us for specific information on other lots.

Quality Assurance

Product Datasheets

79289.pdf